Tymon-Rosario J, Siegel ER, Bellone S, Harold J, et al. Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neu. Gynecol Oncol 2021 Aug 6. pii: S0090-8258(21)00599.
PMID: 34372971